Document is current
Any future updates will be listed below
-
Authors
Zhao, Yulin
Ye, Cong
Wang, Heng
Chen, Cheng
Lu, Yang
Yang, Changwei
Xu, Tao
Zhou, Yuchen
Wu, Zhengchao
Song, Xianrui
Zhu, Zhenyang
Yang, Zongze
Chen, Xiaoqing https://orcid.org/0000-0002-7739-3493
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82371383)
Medical Research Projects of the Health Commission of Jiangsu Province (K2023006)
Postgraduate Research & Practice Innovation Program of Jiangsu Province (SJCX24_2061)
Grants from Jiangsu Provincial Research Hospital (YJXYY202204)
- License Information
-
More Information
Article History
Received: 5 November 2024
Accepted: 2 May 2025
First Online: 28 May 2025
Declarations
:
: The relevant procedures for extraction of human umbilical cord mesenchymal stem cells were approved by the Ethics Committee of Affiliated Hospital of Nantong University. The research project named "Mechanism of GelMA hydrogel encapsulation of umbilical cord mesenchymal stem cells spheroids promoting spinal cord injury repair" was approved on March 6, 2024 (No. 2024-L162) and informed consent was obtained from the donor of each adipose tissue. The HUVECs and PC12 cell lines used in this study were purchased from Wuhan Procell Biotechnology Co., Ltd. The cells source company Procell obtained prior ethical approval to collect human cells, and all donors signed informed consent forms. All experimental procedures used in this study were approved by the Animal Care and Use Committee of Nantong University (Title of project: Mesenchymal Stem Cell Sheet Loaded with Plant Polyphenols Promote the Repair of Spinal Cord Injury; No. S20240720-004) and were following the National Research Council's Guide for the Care and Use of Laboratory Animals. Date of approval: 20/07/2024. The work has been reported in line with the ARRIVE guidelines 2.0.
: Not applicable.
: The authors declare that they have no competing interests.
